- Report
- February 2024
- 73 Pages
Middle East, Africa, Europe Middle East, Africa, Europe
From €4533EUR$4,750USD£3,798GBP
- Report
- November 2023
- 189 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- April 2022
- 560 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- June 2023
- 92 Pages
Asia Pacific
From €1432EUR$1,500USD£1,199GBP
- Report
- June 2023
- 92 Pages
Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- August 2022
United States
From €1851EUR$1,940USD£1,551GBP
- Report
- August 2022
Global
From €945EUR$990USD£792GBP
- Report
- May 2022
- 163 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- August 2022
- 324 Pages
Global
From €3665EUR$3,840USD£3,071GBP
The Opioid Addiction market is a subset of the Addiction Disorders Drugs market, which includes medications used to treat substance use disorders. Opioid Addiction medications are used to treat opioid use disorder, a condition characterized by compulsive opioid use despite negative consequences. These medications work by blocking the effects of opioids, reducing cravings, and helping to prevent relapse. Common medications used to treat opioid addiction include buprenorphine, methadone, and naltrexone.
The Opioid Addiction market is highly regulated, with strict guidelines for prescribing and dispensing medications. In addition, many of these medications require special training and certification for healthcare providers.
Companies in the Opioid Addiction market include Reckitt Benckiser, Indivior, Orexo, and Braeburn Pharmaceuticals. Show Less Read more